2 NEWLY ESTABLISHED CELL-LINES DERIVED FROM THE SAME COLONIC ADENOCARCINOMA EXHIBIT DIFFERENCES IN EGF-RECEPTOR LIGAND AND ADHESION MOLECULE EXPRESSION

被引:13
|
作者
SOLIC, N
COLLINS, JE
RICHTER, A
HOLT, SJ
CAMPBELL, I
ALEXANDER, P
DAVIES, DE
机构
[1] SOUTHAMPTON GEN HOSP,CRC,MED ONCOL UNIT,SOUTHAMPTON SO16 6YD,HANTS,ENGLAND
[2] PRINCESS ANNE HOSP,DEPT HUMAN REPROD,SOUTHAMPTON,HANTS,ENGLAND
关键词
D O I
10.1002/ijc.2910620111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two morphologically distinct cell lines, GP2d and GP5d, derived from the same adenocarcinoma of the colon, have been established and characterized. Both clones have the same genetic changes, consistent with the usual pattern of tumour progression in colon cancer. The cells also have an inverted duplication of bands 10q11 to 10q21, but Southern blot analysis failed to identify any translocations involving the ret proto-oncogene, which maps to this region. GP2d grew by spreading from the edges of microcolonies to form a confluent layer of cells. GP5d grew in discrete islands of cells forming multilayered colonies. These differing patterns of growth correlated with variation in expression or cellular distribution of alpha(2)-integrin, desmoplakin and e-cadherin. Only GP2d responded to exogenously added epidermal growth factor (EGF), transforming growth factor-alpha (TGF alpha) or insulin with an increase in cell numbers, even though both cell lines possessed similar numbers of EGF receptors. Analysis of EGF receptor ligand expression showed that GP5d cells expressed relatively more TGF alpha mRNA than did GP2d; in contrast, amphiregulin mRNA, which was abundant in GP2d, was virtually undetectable in GP5d. Even though GP5d failed to exhibit a growth response to EGF, it underwent a marked epithelial-mesenchymal transition when treated with EGF, indicating separation of growth and morphological responses to EGF. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:48 / 57
页数:10
相关论文
共 4 条
  • [1] THE ESTABLISHMENT AND CHARACTERIZATION OF 2 NEW CELL-LINES DERIVED FROM A SINGLE HUMAN COLONIC ADENOCARCINOMA
    VERSTIJNEN, CPHJ
    ARENDS, JW
    MOERKERK, PTM
    GERAEDTS, JPM
    SEKIKAWA, K
    UITENDAAL, MP
    BOSMAN, FT
    VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1987, 53 (04) : 191 - 197
  • [2] IDENTICAL EXPRESSION OF CELL-SURFACE MEMBRANE-ANTIGENS ON 2 PARENT AND 18 CLONED CELL-LINES DERIVED FROM 2 DIFFERENT NEUROBLASTOMA METASTASES OF THE SAME PATIENT
    SUGIMOTO, T
    SAWADA, T
    MATSUMURA, T
    KEMSHEAD, JT
    ISHII, T
    HORII, Y
    MORIOKA, H
    MORITA, M
    REYNOLDS, CP
    CANCER RESEARCH, 1986, 46 (09) : 4765 - 4769
  • [3] INDUCTION OF COMPLEMENT RECEPTOR EXPRESSION IN CELL-LINES DERIVED FROM HUMAN UNDIFFERENTIATED LYMPHOMAS .2. CHARACTERIZATION OF THE INDUCED COMPLEMENT RECEPTORS AND DEMONSTRATION OF THE SIMULTANEOUS INDUCTION OF EBV RECEPTOR
    MAGRATH, I
    FREEMAN, C
    SANTAELLA, M
    GADEK, J
    FRANK, M
    SPIEGEL, R
    NOVIKOVS, L
    JOURNAL OF IMMUNOLOGY, 1981, 127 (03): : 1039 - 1043
  • [4] CHARACTERIZATION AND COMPARISON OF 2 NEWLY ESTABLISHED EPSTEIN-BARR-VIRUS EBV-NEGATIVE AND EBV-POSITIVE BURKITTS-LYMPHOMA CELL-LINES - EBV-NEGATIVE CELL-LINE WITH A LOW-LEVEL OF EXPRESSION OF ICAM-1 MOLECULE AND EBV-POSITIVE CELL-LINE WITH A HIGH-LEVEL OF EXPRESSION OF ICAM-1 MOLECULE
    ABE, M
    TASAKI, K
    TOMINAGA, K
    FUKUHARA, S
    IMAI, S
    OSATO, T
    WAKASA, H
    CANCER, 1992, 69 (03) : 763 - 771